Have your own idea? Try our Stock Screener
Polish (WIG) Pharma Industry Analysis
UpdatedDec 22, 2024
DataAggregated Company Financials
Companies6
- 7D0.6%
- 3M-11.2%
- 1Y26.7%
- YTD25.0%
In the last week, the Pharma industry is flat overall, with Cannabis Poland standing out by going down 13%. The past year has been better, since the industry has gained 27% in that time. Looking forward, earnings are forecast to decline by 30% per year.
Industry Valuation and Performance
Has the Polish Pharma Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Sun, 22 Dec 2024 | zł1.6b | zł318.9m | -zł9,295,998.00 | 41.4x | -172.3x | 5x |
| Tue, 19 Nov 2024 | zł1.7b | zł314.5m | -zł72,767,518.00 | 10.7x | -23x | 5.3x |
| Thu, 17 Oct 2024 | zł1.9b | zł314.5m | -zł72,767,518.00 | 10.2x | -25.6x | 5.9x |
| Sat, 14 Sep 2024 | zł1.9b | zł317.3m | -zł60,178,104.00 | 12.8x | -31.1x | 5.9x |
| Mon, 12 Aug 2024 | zł1.8b | zł310.8m | -zł61,217,640.00 | 11.7x | -30.1x | 5.9x |
| Wed, 10 Jul 2024 | zł1.8b | zł310.8m | -zł61,217,640.00 | 11.9x | -28.7x | 5.6x |
| Fri, 07 Jun 2024 | zł1.1b | zł312.1m | -zł61,350,052.00 | 11.4x | -18.5x | 3.6x |
| Sun, 05 May 2024 | zł1.1b | zł310.9m | -zł43,157,065.00 | 15.1x | -26.4x | 3.7x |
| Tue, 02 Apr 2024 | zł1.2b | zł311.5m | -zł40,173,065.00 | 15.5x | -29.1x | 3.8x |
| Thu, 29 Feb 2024 | zł1.2b | zł311.5m | -zł40,173,065.00 | 15.2x | -29.9x | 3.9x |
| Sat, 27 Jan 2024 | zł1.2b | zł308.7m | -zł39,880,934.00 | 12.8x | -29.5x | 3.8x |
| Mon, 25 Dec 2023 | zł1.2b | zł308.7m | -zł39,880,934.00 | 11.7x | -29.9x | 3.9x |
| Wed, 22 Nov 2023 | zł1.1b | zł304.0m | -zł44,732,934.00 | 11.2x | -24.6x | 3.6x |
| Fri, 20 Oct 2023 | zł1.1b | zł302.0m | -zł42,933,291.00 | 11.2x | -26.4x | 3.8x |
| Sun, 17 Sep 2023 | zł1.2b | zł287.0m | -zł53,857,118.00 | 11.2x | -21.5x | 4x |
| Tue, 15 Aug 2023 | zł1.2b | zł277.2m | -zł53,957,528.00 | 11.5x | -22.3x | 4.3x |
| Thu, 13 Jul 2023 | zł1.2b | zł278.4m | -zł53,806,540.00 | 36.9x | -23.1x | 4.5x |
| Sat, 10 Jun 2023 | zł1.2b | zł282.0m | -zł51,275,141.00 | 36.1x | -23x | 4.2x |
| Mon, 08 May 2023 | zł1.1b | zł275.3m | -zł51,408,128.00 | 9.1x | -21.3x | 4x |
| Wed, 05 Apr 2023 | zł1.2b | zł273.2m | -zł44,427,333.00 | 8.9x | -26x | 4.2x |
| Fri, 03 Mar 2023 | zł1.1b | zł273.2m | -zł44,427,333.00 | 8.2x | -25.6x | 4.2x |
| Sun, 29 Jan 2023 | zł1.2b | zł270.3m | -zł44,201,704.00 | 8.1x | -26.4x | 4.3x |
| Tue, 27 Dec 2022 | zł971.4m | zł270.3m | -zł44,201,704.00 | 8x | -22x | 3.6x |
| Thu, 24 Nov 2022 | zł990.4m | zł265.4m | -zł40,562,510.00 | 7.6x | -24.4x | 3.7x |
| Sat, 22 Oct 2022 | zł861.1m | zł260.9m | -zł40,391,998.00 | 9.8x | -21.3x | 3.3x |
| Mon, 19 Sep 2022 | zł969.8m | zł265.6m | -zł29,272,739.00 | 9.7x | -33.1x | 3.7x |
| Wed, 17 Aug 2022 | zł1.2b | zł265.7m | -zł29,303,736.00 | 10.1x | -39.9x | 4.4x |
| Fri, 15 Jul 2022 | zł1.0b | zł264.2m | -zł29,985,890.00 | 10.4x | -34.9x | 4x |
| Sun, 12 Jun 2022 | zł1.3b | zł264.2m | -zł29,985,890.00 | 12.4x | -42.6x | 4.8x |
| Tue, 10 May 2022 | zł1.6b | zł236.1m | -zł2,279,146.00 | 56.4x | -681.7x | 6.6x |
| Thu, 07 Apr 2022 | zł1.8b | zł358.1m | zł72.0m | 13.1x | 24.8x | 5x |
| Sat, 05 Mar 2022 | zł1.6b | zł358.1m | zł72.0m | 12.4x | 22.4x | 4.5x |
| Mon, 31 Jan 2022 | zł2.1b | zł350.0m | zł71.4m | 16.6x | 28.9x | 5.9x |
| Wed, 29 Dec 2021 | zł2.2b | zł350.0m | zł71.4m | 13.1x | 30.4x | 6.2x |
Price to Earnings Ratio
30.4x
Current Industry PE
- Investors are optimistic on the Polish Pharmaceuticals industry, and appear confident in long term growth rates.
- The 3-year average PS ratio of 4.5x is lower than the industry's current PS ratio of 5.0x.
Past Earnings Growth
- Total earnings for the Pharmaceuticals industry have declined over the last three years, with the industry now making a loss overall.
- Revenues have also declined 3.0% per year, which is driving profits down.
Industry Trends
Which industries have driven the changes within the Polish Healthcare industry?
| PL Market | -2.62% | |
| Healthcare | -2.63% | |
| Pharma | 0.56% | |
| Pharma | 0.56% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| CLN Celon Pharma | zł25.00 | 1.0% +zł13.5m | 56.8% | PE72.7x | |
| GRZ Green Zebras Spolka Akcyjna | zł14.00 | 3.7% +zł663.9k | n/a | n/a |